Molly’s Participation in Research Applications

 

SCIENTIFIC PEER REVIEW OF CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS’ BREAST CANCER RESEARCH PROGRAM FOR THE DEPARTMENT OF DEFENSE

The Congressionally Directed Medical Research Programs’ (CDMRP), Breast Cancer Research Program (BCRP) consumer advocate Molly MacDonald recently participated in the evaluation of research applications submitted to the BCRP. Molly MacDonald was nominated for participation in the program by Ann Fonfa of the Annie Appleseed Project. As a consumer reviewer, she was a full voting member (along with prominent scientists) at meetings to help determine how the $150 million appropriated by Congress for Fiscal Year 2020 will be spent on breast cancer research.

Consumer reviewers are asked to represent the collective view of patients by preparing comments on the impact of the research on issues such as diagnosis, treatment and quality of life.

Consumer advocates and scientists have worked together in this unique partnership to evaluate the scientific merit of research applications since FY92. Colonel Stephen J. Dalal, Director of the CDMRP, expressed his appreciation for the consumer advocate’s perspective during the scientific review sessions. “Consumer advocates are an integral part of the CDMRP’s scientific review process. They provide a key ingredient to the review process, the patient’s perspective, which is real and urgent. The collaboration of consumer advocates alongside the scientists’ subject matter expertise is a truly unique collaboration that is difficult to find in most medical research programs.”

Scientists applying propose to conduct innovative research focused on the urgency of ending breast cancer and enhancing the well-being of patients experiencing the impact of breast cancer. The BCRP fills important gaps not addressed by other funding agencies by supporting groundbreaking, high-risk, high-gain research while encouraging out-of-the-box thinking.

More information about the CDMRP’s BCRP is available at the website.

Media Contact:
Jennie Mettert-Young,
Public Affairs Specialist

Ripple Effect

Supporting the Congressionally Directed Medical Research Programs, USAMRMC

301-619-9783

Jennie.L.Mettert-Young.ctr@mail.mil

The Financial Side Effects of Cancer

Financial Toxicity

Financial-Toxicity

130% increase in financial difficulties for patients in active treatment

Job Loss

Breast Cancer Stats

Between 20-30% of women diagnosed with breast cancer will lose their jobs

Bankruptcy

Bankruptcies

10M will be unable to pay for rent, food & utilities because of medical bills

Impact on Savings

Impact on Savings

76% of full time workers nationwide live paycheck to paycheck

Get Real Help

Apply

If you or a family member is undergoing treatment for breast cancer and have lost all or a part of income during active treatment, learn more about how The Pink Fund can help.

Apply Now

Give Real Help

Donate

We rely on the generosity of people like you. Donate online and help breast cancer patients in treatment pay their bills so they can concentrate on what is most important... healing.

Donate Now

Enter password to access the Media Kit

Please enter the correct password